Dr. Ridhmi P. Rajapakse, MD

Dr. Rajapakse practices at Fresenius Kidney Care Sparks in Spanish Springs, Nevada.

Dr. Rajapakse's NPI, 1356669766, was assigned on May 10, 2010. Dr. Rajapakse graduated from Beijing Medical University in 2003. Dr. Rajapakse holds Nevada license 22409.

Dr. Rajapakse's primary practice is Fresenius Kidney Care Sparks, at 5915 S Los Altos Pkwy, Spanish Springs, NV 89436 in Washoe County. The practice phone is (775) 200-0108.

Dr. Rajapakse's primary practice is Fresenius Kidney Care Sparks in Spanish Springs, Nevada. Dr. Rajapakse is also affiliated with Northern Nevada Medical Center. The medical group on file is Sierra Nevada Specialty Care. Dmand AI also links Dr. Rajapakse to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajapakse practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rajapakse's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rajapakse is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rajapakse's licenses on file in 5 states: Nevada, Oregon, Utah, New York and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and hypercalcemia among the conditions Dr. Rajapakse treats.

CMS data shows 1,318 Medicare services from Dr. Rajapakse across 13 procedure codes in 2024, for 359 Medicare patients. Medicare paid $155,297 for them.

CMS counts 359 Medicare patients who saw Dr. Rajapakse in 2024. The largest group is 75 to 84, with 124 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 3.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rajapakse's median patient age at 70, with 46% women.

In 2024, Dr. Rajapakse wrote 540 Medicare Part D claims for 157 patients. 84% of them were for generic drugs. CMS names the drug for 383 of them, across 13 drugs with 11 or more claims each, at $126,742 in total drug cost. In 2023, CMS named 388 claims across 14 drugs.

Dr. Rajapakse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rajapakse as offering telehealth.

Dmand AI links 2 papers to Dr. Rajapakse in 2017. The most frequent topics are Helicobacter Infections and Helicobacter pylori. Dr. Rajapakse's most frequent co-authors are Wisit Cheungpasitporn, MD, Veeravich Jaruvongvanich, MD and Kiran Reddy Nakkala, MD, MPH.

CMS Open Payments shows 114 general payments to Dr. Rajapakse from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 90% of the total. Novartis Pharmaceuticals Corporation paid the most, $580.

Dr. Rajapakse graduated from Beijing Medical University in 2003.

Dr. Rajapakse is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.